白血G蛋白结合受体的结构多样性
Aleksandra Luginina1, Anastasiia Gusach1, Elizaveta Lyapina1
1Research Сenter for Molecular Mechanisms of Aging and Age-related Diseases, Moscow Institute of Physics and Technology, Dolgoprudny, Russia.
The Journal of biological chemistry
|September 13, 2023
概括
对白细胞三烯 (LT) 受体的结构洞察力揭示了不同的分子架构. 这一发现使基于结构的药物设计能够用于针对BLT和CysLT受体的新型抗炎疗法.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 结构生物学 结构生物学
背景情况:
- 胆固醇蛋白 (LTs) 是关键的炎症调解剂.
- 通过不同的G蛋白结合受体 (GPCR) 家族传递LTs信号:BLT和CysLT受体.
- 准LT受体为炎症性疾病提供了治疗潜力.
研究的目的:
- 审查BLT1R和CysLTRs最近的结构数据.
- 突出LT受体家族之间独特的结构特征和差异.
- 为新疗法提供基于结构的药物设计提供信息.
主要方法:
- 在X射线晶体学.
- 低温电子显微镜 (cryo-EM) 是一种电子显微镜.
- 基于结构的药物设计.
主要成果:
- 揭示了BLT1R和CysLTRs的独特结构特征.
- 详细的受体构造,激活动机和连接体结合口袋.
- 在BLT1R中发现了BIIL260的意想不到的结合模式,针对结合部位.
结论:
- 在BLT和CysLT受体家族的分子结构中存在显著的差异.
- 结构数据为新的治疗策略铺平了道路.
- 允许针对性药物设计来选择性调节单个LT受体.
更多相关视频
相关概念视频
G Protein-coupled Receptors
12.2K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
12.2K
Transducer Mechanism: G Protein–Coupled Receptors
2.1K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.1K
G-protein Coupled Receptors
120.2K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
120.2K
Diversity of Antigen Receptors
627
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
627
Activation and Inactivation of G Proteins
7.2K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
7.2K
Antiasthma Drugs: Leukotriene Modifiers
343
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
343


